https://stg-admare-staging.kinsta.cloud/en/news-events/ 2026-06-26T18:52:15+00:00 https://stg-admare-staging.kinsta.cloud/fr/nouvelles-et-evenements/ 2026-06-26T18:52:15+00:00 https://stg-admare-staging.kinsta.cloud/fr/nouvelles-et-evenements/actualites-et-perspectives/pathway-to-cures-invests-in-seragene-therapeutics/ 2026-03-23T19:35:17+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2026/03/gettyimages-477042415-170667a.jpg https://stg-admare-staging.kinsta.cloud/fr/nouvelles-et-evenements/actualites-et-perspectives/fr-new-admare-institute-report-examines-capital-flows-in-canadian-life-sciences-and-the-urgent-need-to-capture-domestic-economic-value-duplicate/ 2026-04-23T20:11:37+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2026/03/accelmay2024en-1763649271.png https://stg-admare-staging.kinsta.cloud/fr/nouvelles-et-evenements/actualites-et-perspectives/admare-bioinnovations-inaugure-officiellement-le-centre-dinnovation-m4-a-vancouver-pour-soutenir-la-croissance-de-compagnies-des-sciences-de-la-vie-du-canada/ 2026-04-24T16:14:57+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2026/04/annoucement_m4_fr-1776363947.png https://stg-admare-staging.kinsta.cloud/fr/nouvelles-et-evenements/actualites-et-perspectives/ocythera-obtient-un-financement-damorcage-dadmare-bioinnovations-et-du-fonds-impulsion-pour-faire-progresser-des-therapies-contre-les-maladies-osseuses-rares/ 2026-05-04T19:24:21+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2026/01/ocythera_fr-1769531789.png https://stg-admare-staging.kinsta.cloud/fr/nouvelles-et-evenements/actualites-et-perspectives/abbvie-et-admare-bioinnovations-nomment-rime-therapeutics-laureat-du-prix-abbvie-des-innovateurs-en-biotechnologies-au-quebec/ 2026-05-05T14:35:46+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2026/04/announcement-1-1777575859.png https://stg-admare-staging.kinsta.cloud/fr/nouvelles-et-evenements/actualites-et-perspectives/epitopea-annonce-lapprobation-de-la-demande-dessai-clinique-ovact-pour-le-cryptivax-1001-dans-le-cancer-de-lovaire-sereux-de-haut-grade-avance/ 2026-05-05T14:41:33+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2026/05/epitopea-news-fr-1739974973.png https://stg-admare-staging.kinsta.cloud/fr/nouvelles-et-evenements/actualites-et-perspectives/therapeutiques-thryv-commence-ladministration-du-traitement-aux-patients-dans-le-cadre-de-letude-clinique-wave-ii-pour-le-sqtl-et-recoit-la-designation-fast-track-de-la-fda-pour-le-thrv-126/ 2026-06-26T13:07:30+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2026/05/thryv-therapeutics-fr-1-1758136900.png https://stg-admare-staging.kinsta.cloud/fr/nouvelles-et-evenements/actualites-et-perspectives/kainova-therapeutiques-etend-lessai-clinique-de-phase-i-ii-domisol-avec-le-traitement-du-premier-patient-en-europe-evaluant-dt-7012-un-anticorps-anti-ccr8-depletant-les-tregs/ 2026-06-26T13:07:30+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2026/05/zymeworks-en-1768231861.png https://stg-admare-staging.kinsta.cloud/fr/nouvelles-et-evenements/actualites-et-perspectives/annonce-de-la-direction-dadmare-bioinnovations/ 2026-06-26T13:07:30+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2026/03/fr-leadership-1774897290.png https://stg-admare-staging.kinsta.cloud/fr/nouvelles-et-evenements/actualites-et-perspectives/genome-canada-et-ontario-genomics-attribuent-une-subvention-de-18-million-de-dollars-a-specific-biologics-et-a-western-university-pour-developper-une-plateforme-dapprentissage-automatique-vi/ 2026-06-26T13:07:30+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2026/05/specificfr-1749651003.png https://stg-admare-staging.kinsta.cloud/fr/nouvelles-et-evenements/actualites-et-perspectives/kainova-therapeutiques-annonce-des-resultats-positifs-de-phase-i-pour-dt-9081-antagoniste-du-recepteur-ep4r-dans-les-tumeurs-solides-avancees/ 2026-06-26T13:07:30+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2026/05/zymeworks-en-1768231861-1.png https://stg-admare-staging.kinsta.cloud/news-events/news-insights/epitopea-announces-approval-of-ovact-clinical-trial-application-for-cryptivax-1001-in-advanced-high-grade-serous-ovarian-cancer/ 2026-06-26T13:07:30+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2026/05/epitopeanews-en-1739975092.png https://stg-admare-staging.kinsta.cloud/news-events/news-insights/admare-bioinnovations-officially-opens-m4-innovation-centre-in-vancouver-to-support-the-growth-of-life-sciences-companies-in-canada/ 2026-06-26T13:07:30+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2026/04/annoucement_m4_eng-1776364058.png https://stg-admare-staging.kinsta.cloud/fr/nouvelles-et-evenements/actualites-et-perspectives/26therapeutics-inc-une-nouvelle-compagnie-biotechnologique-canadienne-sattaque-a-la-cause-fondamentale-de-la-secheresse-oculaire-grace-a-une-therapie-de-premiere-classe/ 2026-06-26T13:07:31+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2026/03/26tx_fr-1772591581.png https://stg-admare-staging.kinsta.cloud/fr/nouvelles-et-evenements/actualites-et-perspectives/kainova-therapeutiques-securise-32-millions-de-cad-pour-accelerer-le-developpement-de-son-portefeuille-en-immuno-oncologie-et-inflammation/ 2026-06-26T13:07:31+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2026/05/zymeworks-en-1768231861-1.png https://stg-admare-staging.kinsta.cloud/fr/nouvelles-et-evenements/actualites-et-perspectives/admare-bioinnovations-annonce-la-creation-docythera-une-nouvelle-compagnie-canadienne-en-sciences-de-la-vie-qui-fait-progresser-les-therapies-pour-les-maladies-osseuses-rares/ 2026-06-26T13:07:31+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2026/01/annonce_ocythera-1768345460.png https://stg-admare-staging.kinsta.cloud/fr/nouvelles-et-evenements/actualites-et-perspectives/therapeutiques-thryv-lance-wave-ii-une-etude-pivotale-de-phase-2-3-sur-le-syndrome-du-qt-long-de-type-2/ 2026-06-26T13:07:31+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2026/05/thryv-therapeutics-fr-1-1758136900.png https://stg-admare-staging.kinsta.cloud/fr/nouvelles-et-evenements/actualites-et-perspectives/domain-therapeutics-devient-kainova-therapeutiques-et-fait-progresser-son-pipeline-clinique-de-therapies-modulatrices-rcpg/ 2026-06-26T13:07:31+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2026/05/zymeworks-en-1768231861-1.png https://stg-admare-staging.kinsta.cloud/fr/nouvelles-et-evenements/actualites-et-perspectives/find-therapeutics-annonce-une-extension-de-son-financement-de-serie-a-et-la-nomination-du-dr-thierry-abribat-a-la-presidence-executive-de-son-conseil-dadministration/ 2026-06-26T13:07:32+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2026/05/find-therapeutics-fr-1744304415.png https://stg-admare-staging.kinsta.cloud/fr/nouvelles-et-evenements/actualites-et-perspectives/therapeutiques-thryv-annonce-des-resultats-positifs-de-letude-de-phase-1-du-thrv-1268-chez-des-participants-obeses/ 2026-06-26T13:07:32+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2026/05/thryv-therapeutics-fr-1-1758136900.png https://stg-admare-staging.kinsta.cloud/fr/nouvelles-et-evenements/actualites-et-perspectives/specific-biologics-accueille-le-leader-chevronne-en-biotechnologie-le-dr-richard-glickman-au-sein-de-son-conseil-dadministration/ 2026-06-26T13:07:32+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2026/05/specificfr-1749651003.png https://stg-admare-staging.kinsta.cloud/fr/nouvelles-et-evenements/actualites-et-perspectives/admare-bioinnovations-lance-la-cohorte-viii-de-linstitut-pour-cadres-superieurs-visant-a-renforcer-le-leadership-propulsant-la-croissance-des-compagnies-canadiennes-en-sciences-de-la-vie/ 2026-06-26T13:07:32+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2025/12/ei_cohort-viii_fr-1765477633.png https://stg-admare-staging.kinsta.cloud/fr/nouvelles-et-evenements/actualites-et-perspectives/therapeutiques-thryv-renforce-son-equipe-de-direction-avec-la-nomination-de-matt-killeen-phd-au-poste-de-directeur-des-affaires-commerciales-chief-business-officer/ 2026-06-26T13:07:32+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2026/05/thryv-therapeutics-fr-1-1758136900.png https://stg-admare-staging.kinsta.cloud/fr/nouvelles-et-evenements/actualites-et-perspectives/lancement-du-prix-abbvie-des-innovateurs-en-biotechnologies-au-quebec-abbvie-et-admare-bioinnovations-encouragent-linnovation-dans-le-domaine-des-sciences-de-la-vie/ 2026-06-26T13:08:01+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2026/05/announcement-1-1763995590.png https://stg-admare-staging.kinsta.cloud/fr/nouvelles-et-evenements/actualites-et-perspectives/pathway-to-cures-investit-dans-seragene-therapeutics/ 2026-06-26T13:08:01+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2026/05/accelmay2024en-1763649153.png https://stg-admare-staging.kinsta.cloud/fr/nouvelles-et-evenements/actualites-et-perspectives/amy-rudolph-phd-rejoint-le-conseil-dadministration-de-therapeutiques-thryv-inc-pour-soutenir-la-progression-du-portefeuille-vers-linsuffisance-cardiaque/ 2026-06-26T13:08:01+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2026/05/thryv-therapeutics-fr-1-1758136900.png https://stg-admare-staging.kinsta.cloud/fr/nouvelles-et-evenements/actualites-et-perspectives/domain-therapeutics-administre-les-premieres-doses-aux-patients-dans-un-essai-de-phase-i-ii-de-dt-7012-ciblant-ccr8-dans-les-tumeurs-solides/ 2026-06-26T13:08:02+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2026/05/domain-tx-fr-1686256265.png https://stg-admare-staging.kinsta.cloud/fr/nouvelles-et-evenements/actualites-et-perspectives/epitopea-renforce-son-comite-consultatif-scientifique-avec-la-nomination-de-quatre-experts-de-renommee-mondiale-en-immunologie-et-immunotherapie-du-cancer/ 2026-06-26T13:08:02+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2026/05/epitopea-news-fr-1739974973.png https://stg-admare-staging.kinsta.cloud/fr/nouvelles-et-evenements/actualites-et-perspectives/therapeutiques-thryv-annonce-lautorisation-ind-par-la-fda-pour-thrv-1268-dans-le-syndrome-du-qt-long/ 2026-06-26T13:08:02+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2026/05/thryv-therapeutics-fr-1-1758136900.png https://stg-admare-staging.kinsta.cloud/fr/nouvelles-et-evenements/actualites-et-perspectives/abdera-therapeutics-presente-les-premieres-donnees-cliniques-de-phase-1-sur-labd-147-une-therapie-radiopharmaceutique-de-nouvelle-generation-ciblant-dll3-lors-du-congres-mondial-2025-de-l/ 2026-06-26T13:08:02+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2026/05/abdera-therapeutics-fr-1757440786.png https://stg-admare-staging.kinsta.cloud/fr/nouvelles-et-evenements/actualites-et-perspectives/thryv-therapeutiques-recoit-lautorisation-ind-de-la-fda-pour-thrv-1268-dans-linsuffisance-cardiaque-et-la-fibrillation-auriculaire-et-presente-des-resultats-sgk1-et-jardiance-au-cong/ 2026-06-26T13:08:03+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2026/05/thryv-therapeutics-fr-1-1758136900.png https://stg-admare-staging.kinsta.cloud/fr/nouvelles-et-evenements/actualites-et-perspectives/epitopea-renforce-ses-capacites-de-recherche-et-de-developpement-clinique-pour-accelerer-le-passage-a-la-clinique/ 2026-06-26T13:08:03+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2026/05/epitopea-news-fr-1739974973.png https://stg-admare-staging.kinsta.cloud/fr/nouvelles-et-evenements/actualites-et-perspectives/un-nouveau-rapport-de-linstitut-admare-examine-les-flux-de-capitaux-dans-le-secteur-canadien-des-sciences-de-la-vie-et-lurgence-de-mieux-capter-la-valeur-economique-au-pays/ 2026-06-26T13:08:03+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2026/05/heading-1752065028.png https://stg-admare-staging.kinsta.cloud/fr/nouvelles-et-evenements/actualites-et-perspectives/9bio-therapeutiques-selectionnee-par-le-merck-global-health-innovation-fund-et-le-cqdm-pour-un-investissement-strategique-et-un-programme-dacceleration/ 2026-06-26T13:08:03+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2026/05/accelmay2024en-2-1740158128.png https://stg-admare-staging.kinsta.cloud/fr/nouvelles-et-evenements/actualites-et-perspectives/specific-biologics-accueille-paul-j-hastings-a-titre-de-president-du-conseil-dadministration/ 2026-06-26T13:08:03+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2026/05/specificfr-1749651003.png https://stg-admare-staging.kinsta.cloud/fr/nouvelles-et-evenements/actualites-et-perspectives/epitopea-annonce-un-article-dans-nature-cancer-sur-de-nouvelles-cibles-dimmunotherapie-dans-le-melanome-et-le-cancer-du-poumon-non-a-petites-cellules-nsclc/ 2026-06-26T13:08:04+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2026/05/epitopea-news-fr-1739974973.png https://stg-admare-staging.kinsta.cloud/fr/nouvelles-et-evenements/actualites-et-perspectives/une-collaboration-appuyee-par-le-quebec-a-hauteur-de-18-m-entre-9bio-et-vega-fait-progresser-linnovation-en-oncologie-de-precision/ 2026-06-26T13:08:04+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2025/06/accelmay2024en-2-1740158243.png https://stg-admare-staging.kinsta.cloud/fr/nouvelles-et-evenements/actualites-et-perspectives/zucara-therapeutics-annonce-une-deuxieme-et-derniere-cloture-de-son-financement-de-serie-b-totalisant-25-millions-us/ 2026-06-26T13:08:04+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2026/05/zucaranews-fr-1746106189.png https://stg-admare-staging.kinsta.cloud/fr/nouvelles-et-evenements/actualites-et-perspectives/deux-expertises-cles-pour-accelerer-le-developpement-de-ftx-101/ 2026-06-26T13:08:04+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2026/05/find-therapeutics-fr-1744304415.png https://stg-admare-staging.kinsta.cloud/fr/nouvelles-et-evenements/actualites-et-perspectives/9bio-therapeutiques-obtient-un-financement-strategique-pour-faire-progresser-son-pipeline-en-oncologie/ 2026-06-26T13:08:04+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2026/05/accelmay2024en-2-1740158128.png https://stg-admare-staging.kinsta.cloud/fr/nouvelles-et-evenements/actualites-et-perspectives/epitopea-annonce-un-accord-de-licence-et-de-collaboration-en-recherche-avec-msd-pour-identifier-les-antigenes-tumoraux-specifiques-cryptigenmc/ 2026-06-26T13:08:04+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2026/05/epitopea-news-fr-1739974973.png https://stg-admare-staging.kinsta.cloud/fr/nouvelles-et-evenements/actualites-et-perspectives/le-gouvernement-du-canada-investit-6-millions-de-dollars-pour-stimuler-la-croissance-du-secteur-des-sciences-de-la-vie-en-colombie-britannique/ 2026-06-26T13:08:30+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2026/05/annonce-1738953429.png https://stg-admare-staging.kinsta.cloud/fr/nouvelles-et-evenements/actualites-et-perspectives/faits-saillants-2024-dadmare-bioinnovations/ 2026-06-26T13:08:30+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2026/05/5_cie_fr-1734623920.png https://stg-admare-staging.kinsta.cloud/fr/nouvelles-et-evenements/actualites-et-perspectives/zucara-therapeutics-annonce-un-investissement-strategique-de-sanofi-dans-le-cadre-dun-financement-de-serie-b-de-20-millions-de-dollars-us/ 2026-06-26T13:08:30+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2026/05/zucaranews-fr-1746106189.png https://stg-admare-staging.kinsta.cloud/fr/nouvelles-et-evenements/actualites-et-perspectives/admare-bioinnovations-accueille-la-cohorte-vii-de-linstitut-pour-cadres-superieurs-renforcant-ainsi-le-leadership-du-canada-dans-le-domaine-des-sciences-de-la-vie/ 2026-06-26T13:08:31+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2026/05/announcement-3-1-1733349885.png https://stg-admare-staging.kinsta.cloud/fr/nouvelles-et-evenements/actualites-et-perspectives/kisoji-biotechnology-recueille-41-millions-de-dollars-pour-faire-avancer-son-programme-principal-dans-les-etudes-cliniques-et-deployer-des-outils-dia-dans-les-indications-cles-du-pipeline/ 2026-06-26T13:08:31+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2026/05/kisoji-news-fr-1733150499.png https://stg-admare-staging.kinsta.cloud/fr/nouvelles-et-evenements/actualites-et-perspectives/admare-bioinnovations-transfere-son-departement-de-services-analytiques-a-paraza-pharma-stimulant-ainsi-la-croissance-et-linnovation/ 2026-06-26T13:08:31+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2026/05/paraza-fr-1732803378.png https://stg-admare-staging.kinsta.cloud/fr/nouvelles-et-evenements/actualites-et-perspectives/la-fda-approuve-ziihera-zanidatamab-hrii-pour-le-traitement-des-adultes-atteints-dun-cancer-des-voies-biliaires-her2-positif-ihc-3-non-resecable-ou-metastatique-deja-traite/ 2026-06-26T13:08:31+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2026/05/zymeworks-news-fr-1729863330.png https://stg-admare-staging.kinsta.cloud/fr/nouvelles-et-evenements/actualites-et-perspectives/thryv-annonce-lachevement-du-dosage-dans-letude-phase-1-de-son-2e-nouvel-inhibiteur-de-sgk1-thrv-1268-les-etudes-sur-linsuffisance-cardiaque-et-la-fibrillation-auriculaire-debuteront-e/ 2026-06-26T13:08:31+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2026/05/thryv-therapeutics-fr-1-1758136900.png https://stg-admare-staging.kinsta.cloud/fr/nouvelles-et-evenements/actualites-et-perspectives/thryv-therapeutics-receives-positive-top-line-results-from-wave-i-part-2-clinical-study-in-long-qt-syndrome-type-2-and-type-3-patients/ 2026-06-26T13:08:31+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2026/05/thryv-therapeutics-fr-1-1758136900.png https://stg-admare-staging.kinsta.cloud/fr/nouvelles-et-evenements/actualites-et-perspectives/admare-bioinnovations-salue-les-succes-des-compagnies-de-laccelerateur-national-tx-admare-et-termine-son-partenariat-en-ontario-avec-mars/ 2026-06-26T13:08:32+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2026/05/accelannouncfr-1729602403.png https://stg-admare-staging.kinsta.cloud/fr/nouvelles-et-evenements/actualites-et-perspectives/premier-sujet-traite-dans-le-cadre-de-letude-clinique-de-phase-1-du-ftx-101/ 2026-06-26T13:08:32+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2026/05/find-therapeutics-fr-1744304415.png https://stg-admare-staging.kinsta.cloud/fr/nouvelles-et-evenements/actualites-et-perspectives/admare-bioinnovations-nomme-marc-riviere-a-son-conseil-dadministration/ 2026-06-26T13:08:32+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2026/05/marc-riviere-fr-1726843994.png https://stg-admare-staging.kinsta.cloud/fr/nouvelles-et-evenements/actualites-et-perspectives/nanovation-therapeutics-announces-multi-target-partnership-with-novo-nordisk-to-develop-genetic-medicines-targeting-cardiometabolic-and-rare-diseases/ 2026-06-26T13:08:32+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2026/05/nanovation-therapeutics-fr-1728480875.png https://stg-admare-staging.kinsta.cloud/fr/nouvelles-et-evenements/actualites-et-perspectives/find-therapeutiques-annonce-la-cloture-dun-financement-par-debentures-convertibles-avec-investissement-quebec/ 2026-06-26T13:08:32+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2026/05/find-therapeutics-fr-1744304415.png https://stg-admare-staging.kinsta.cloud/fr/nouvelles-et-evenements/actualites-et-perspectives/abdera-therapeutics-announces-fda-orphan-drug-designation-for-abd-147-for-the-treatment-of-neuroendocrine-carcinoma/ 2026-06-26T13:08:32+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2026/05/abdera-therapeutics-fr-1-1728481031.png https://stg-admare-staging.kinsta.cloud/fr/nouvelles-et-evenements/actualites-et-perspectives/sutter-health-deploys-worlds-first-wearable-doppler-ultrasound-patch-to-enhance-safety-of-icu-patients/ 2026-06-26T13:08:32+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2026/05/fmfr-1722441544.png https://stg-admare-staging.kinsta.cloud/fr/nouvelles-et-evenements/actualites-et-perspectives/domain-therapeutics-strengthens-its-intellectual-property-for-its-series-of-treg-depleting-anti-ccr8-antibodies-including-best-in-class-candidate-dt-7012/ 2026-06-26T13:08:32+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2026/05/domain-tx-fr-1686256265.png https://stg-admare-staging.kinsta.cloud/fr/nouvelles-et-evenements/actualites-et-perspectives/cancer-research-uk-et-kisoji-biotechnology-collaborent-pour-faire-avancer-le-premier-anticorps-nu-ciblant-trop2-en-clinique/ 2026-06-26T13:08:33+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2026/05/kisoji-news-fr-1733150499.png https://stg-admare-staging.kinsta.cloud/fr/nouvelles-et-evenements/actualites-et-perspectives/epitopea-conclut-des-ententes-de-financement-prealable-a-la-serie-a-dun-montant-de-31-millions-de-dollars-us/ 2026-06-26T13:08:33+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2026/05/epitopea-news-fr-1739974973.png https://stg-admare-staging.kinsta.cloud/fr/nouvelles-et-evenements/actualites-et-perspectives/gsk-reaches-agreement-to-acquire-late-stage-biopharmaceutical-company-bellus-health/ 2026-06-26T13:08:33+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2026/05/gskbellus-fr-april-18-2023-1682723732.png https://stg-admare-staging.kinsta.cloud/fr/nouvelles-et-evenements/actualites-et-perspectives/abdera-therapeutics-announces-fda-clearance-of-ind-application-for-abd-147/ 2026-06-26T13:08:52+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2026/05/abdera-therapeutics-fr-1-1728481031.png https://stg-admare-staging.kinsta.cloud/fr/nouvelles-et-evenements/actualites-et-perspectives/zymeworks-announces-first-patient-dosed-in-phase-1-clinical-trial-evaluating-zw171-in-advanced-mesothelin-expressing-cancers/ 2026-06-26T13:08:53+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2026/05/zymeworks-news-fr-1729863330.png https://stg-admare-staging.kinsta.cloud/fr/nouvelles-et-evenements/actualites-et-perspectives/thryv-therapeutics-granted-fda-orphan-drug-designation-for-lqt-1213-in-long-qt-syndrome-treatment/ 2026-06-26T13:08:53+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2026/05/thryv-therapeutics-fr-1-1758136900.png https://stg-admare-staging.kinsta.cloud/fr/nouvelles-et-evenements/actualites-et-perspectives/admare-bioinnovations-accueille-cinq-nouvelles-start-ups-au-sein-de-laccelerateur-tx-national/ 2026-06-26T13:08:53+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2026/05/accelmay2024fr-1715966600.png https://stg-admare-staging.kinsta.cloud/fr/nouvelles-et-evenements/actualites-et-perspectives/novo-nordisk-entend-acquerir-inversago-pharma-afin-de-mettre-au-point-de-nouveaux-traitements-pour-les-personnes-atteintes-dobesite-de-diabete-et-dautres-maladies-metaboliques/ 2026-06-26T13:08:53+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2026/05/inversago-fr-1684857999.png https://stg-admare-staging.kinsta.cloud/fr/nouvelles-et-evenements/actualites-et-perspectives/inversago-pharma-annonce-la-presentation-de-nouvelles-donnees-lors-de-la-conference-internationale-ats-2023/ 2026-06-26T13:08:53+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2026/05/inversago-en-1684857860.png https://stg-admare-staging.kinsta.cloud/fr/nouvelles-et-evenements/actualites-et-perspectives/pharmaessentia-announces-licensing-agreement-with-forus-therapeutics-to-commercialize-besremi-ropeginterferon-alfa-2b-njft-in-canada/ 2026-06-26T13:08:54+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2026/05/forusnews-fr-1-1728481165.png https://stg-admare-staging.kinsta.cloud/fr/nouvelles-et-evenements/actualites-et-perspectives/sofiac-canada-rend-possible-la-decarbonation-des-batiments-dadmare-bioinnovations-grace-a-un-investissement-de-3-275-000/ 2026-06-26T13:08:54+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2026/05/admare-infographic-final-fr-1725042599-scaled.jpg https://stg-admare-staging.kinsta.cloud/fr/nouvelles-et-evenements/actualites-et-perspectives/zymeworks-announces-fda-clearance-of-investigational-new-drug-application-for-zw191-a-novel-folate-receptor-%e2%8d%ba-targeted-topoisomerase-i-inhibitor-antibody-drug-conjugate/ 2026-06-26T13:08:54+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2026/05/zymeworks-news-fr-1729863330.png https://stg-admare-staging.kinsta.cloud/fr/nouvelles-et-evenements/actualites-et-perspectives/abdera-therapeutics-announces-fda-fast-track-designation-for-abd-147-a-next-generation-precision-radiopharmaceutical-therapy-for-the-treatment-of-patients-with-extensive-stage-small-cell-lung-cancer/ 2026-06-26T13:08:54+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2026/05/abdera-therapeutics-fr-1-1728481031.png https://stg-admare-staging.kinsta.cloud/fr/nouvelles-et-evenements/actualites-et-perspectives/admare-bioinnovations-sagrandit-avec-un-nouvel-espace-de-laboratoires-a-vancouver/ 2026-06-26T13:08:54+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2026/05/june-28th-french-2-1719515297.png https://stg-admare-staging.kinsta.cloud/fr/nouvelles-et-evenements/actualites-et-perspectives/neurasic-therapeutics-une-entreprise-en-portefeuille-dadmare-recoit-une-nouvelle-subvention-pour-faire-progresser-le-traitement-de-la-douleur-non-opioide/ 2026-06-26T13:08:55+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2026/05/neurasic-news-fr-1685737217.png https://stg-admare-staging.kinsta.cloud/fr/nouvelles-et-evenements/actualites-et-perspectives/la-fda-autorise-lind-pour-letude-clinique-de-phase-1-du-ftx-101/ 2026-06-26T13:08:55+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2026/05/find-therapeutics-fr-1744304415.png https://stg-admare-staging.kinsta.cloud/fr/nouvelles-et-evenements/actualites-et-perspectives/zymeworks-announces-fda-clearance-of-investigational-new-drug-application-for-zw171-a-novel-21-t-cell-targeting-bispecific-antibody-for-mesothelin-expressing-cancers/ 2026-06-26T13:08:55+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2026/05/zymeworks-news-fr-1729863330.png https://stg-admare-staging.kinsta.cloud/fr/nouvelles-et-evenements/actualites-et-perspectives/zymeworks-announces-china-nmpa-acceptance-of-biologics-license-application-for-zanidatamab-for-second-line-treatment-of-biliary-tract-cancer/ 2026-06-26T13:08:55+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2026/05/zymeworks-news-fr-1729863330.png https://stg-admare-staging.kinsta.cloud/fr/nouvelles-et-evenements/actualites-et-perspectives/immugenia-recoit-un-soutien-de-pre-amorcage-dadmare-bioinnovations-acet-capital-et-sherbrooke-innopole-pour-developper-une-therapie-contre-le-cancer-qui-permettrait-de-prevenir-les-rechutes/ 2026-06-26T13:08:55+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2026/05/immugenia-fr-oct-6-2022-1682724336.png https://stg-admare-staging.kinsta.cloud/news-events/news-insights/ocythera-secures-seed-financing-from-admare-bioinnovations-and-fonds-impulsion-to-advance-therapies-for-rare-bone-diseases/ 2026-06-26T14:52:46+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2026/05/ocythera_eng-1769531742.png https://stg-admare-staging.kinsta.cloud/fr/nouvelles-et-evenements/actualites-et-perspectives/admare-bioinnovations-ouvre-les-candidatures-pour-les-cohortes-dautomne-des-programmes-scientifiques-en-bioinnovation/ 2026-06-26T14:58:21+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2026/05/bisaug2024fr-1-1722965029.png https://stg-admare-staging.kinsta.cloud/fr/nouvelles-et-evenements/actualites-et-perspectives/castl-annonce-la-nomination-dun-gestionnaire-de-site-pour-son-centre-de-formation-en-biofabrication-en-colombie-britannique/ 2026-06-26T14:58:42+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2026/05/castl-fr-jan-12-2023-1682724056.png https://stg-admare-staging.kinsta.cloud/fr/nouvelles-et-evenements/actualites-et-perspectives/linstitut-pour-cadres-superieurs-dadmare-ouvre-les-candidatures-pour-sa-huitieme-cohorte/ 2026-06-26T14:58:58+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2026/05/exec-institute-cohort-viii-announcement-1-1753713106.png https://stg-admare-staging.kinsta.cloud/fr/nouvelles-et-evenements/actualites-et-perspectives/alors-que-les-etats-unis-vacillent-le-quebec-doit-tenir-bon-en-sciences-de-la-vie/ 2026-06-26T15:01:26+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2026/05/d2d689d995f73d6583f6ef266bf80233-1762383436.webp https://stg-admare-staging.kinsta.cloud/fr/nouvelles-et-evenements/actualites-et-perspectives/castl-elargit-la-formation-nationale-en-biofabrication-avec-le-programme-bioinnovation-scientist-bis/ 2026-06-26T15:07:35+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2026/05/bis-image-1763743515-1764303858.png https://stg-admare-staging.kinsta.cloud/news-events/news-insights/zymeworks-announces-fda-clearance-of-investigational-new-drug-application-for-zw171-a-novel-21-t-cell-targeting-bispecific-antibody-for-mesothelin-expressing-cancers/ 2026-06-26T16:25:28+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2026/05/zymeworks-en-1729863234.png https://stg-admare-staging.kinsta.cloud/news-events/news-insights/kainova-therapeutics-announces-positive-phase-i-results-for-dt-9081-an-oral-ep4-receptor-antagonist-in-advanced-solid-tumors/ 2026-06-26T17:05:42+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2026/05/zymeworks-en-1768231861-1.png https://stg-admare-staging.kinsta.cloud/news-events/news-insights/thryv-therapeutics-commences-patient-dosing-in-wave-ii-clinical-study-for-long-qt-syndrome-and-receives-fda-fast-track-designation-for-thrv-1268/ 2026-06-26T17:06:30+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2026/05/thryv-therapeutics-eng-1-1758136916-1.png https://stg-admare-staging.kinsta.cloud/news-events/news-insights/kainova-therapeutics-expands-phase-i-ii-trial-of-dt-7012-a-treg-depleting-anti-ccr8-antibody-with-first-patient-dosed-in-europe/ 2026-06-26T17:06:58+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2026/05/zymeworks-en-1768231861.png https://stg-admare-staging.kinsta.cloud/news-events/news-insights/admare-bioinnovations-leadership-announcement/ 2026-06-26T17:10:10+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2026/05/en-leadership-1-1775049276.png https://stg-admare-staging.kinsta.cloud/news-events/news-insights/grant-to-develop-a-machine-learning-platform-to-accelerate-the-development-of-the-companys-dualase-based-therapeutics/ 2026-06-26T17:11:58+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2026/05/specificen-1749651081.png https://stg-admare-staging.kinsta.cloud/news-events/news-insights/domain-therapeutics-rebrands-as-kainova-therapeutics-advancing-its-clinical-pipeline-of-gpcr-modulating-therapies/ 2026-06-26T17:13:18+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2026/05/zymeworks-en-1768231861-1.png https://stg-admare-staging.kinsta.cloud/news-events/news-insights/new-canadian-biotech-26therapeutics-inc-targets-root-cause-of-dry-eye-disease-with-first-in-class-therapy/ 2026-06-26T17:13:47+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2026/05/26tx_eng-1772591710.png https://stg-admare-staging.kinsta.cloud/news-events/news-insights/kainova-therapeutics-secures-32m-cad-to-accelerate-development-of-immuno-oncology-and-inflammation-therapies/ 2026-06-26T17:17:15+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2026/05/zymeworks-en-1768231861-1.png https://stg-admare-staging.kinsta.cloud/news-events/news-insights/admare-bioinnovations-launches-ocythera-a-new-canadian-life-sciences-company-advancing-therapies-for-rare-bone-diseases/ 2026-06-26T17:17:48+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2026/05/ocythera_eng-1768345717.png https://stg-admare-staging.kinsta.cloud/news-events/news-insights/thryv-therapeutics-launches-pivotal-wave-ii-phase-2-3-study-in-long-qt-syndrome-type-2/ 2026-06-26T17:18:17+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2026/05/thryv-therapeutics-eng-1-1758136916-1.png https://stg-admare-staging.kinsta.cloud/news-events/news-insights/castl-expands-national-biomanufacturing-training-with-bioinnovation-scientist-bis-program/ 2026-06-26T17:19:08+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2026/05/bis-image-1763743515-1764303858.png https://stg-admare-staging.kinsta.cloud/news-events/news-insights/thryv-therapeutics-strengthens-senior-leadership-team-with-appointment-of-matt-killeen-phd-as-chief-business-officer/ 2026-06-26T17:19:47+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2026/05/thryv-therapeutics-eng-1-1758136916-1.png https://stg-admare-staging.kinsta.cloud/news-events/news-insights/admare-bioinnovations-launches-cohort-viii-of-the-executive-institute-to-strengthen-leadership-driving-canadian-life-sciences-company-growth/ 2026-06-26T17:20:16+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2026/05/ei_cohort-viii_eng-1765477906.png https://stg-admare-staging.kinsta.cloud/news-events/news-insights/specific-biologics-welcomes-accomplished-biotechnology-leader-dr-richard-glickman-to-its-board-of-directors/ 2026-06-26T17:24:14+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2026/05/specificen-1749651081.png https://stg-admare-staging.kinsta.cloud/news-events/news-insights/find-therapeutics-announces-fda-clearance-of-ind-application-for-a-phase-1-study-of-ftx-101-for-the-treatment-of-chronic-optic-neuropathy/ 2026-06-26T17:46:30+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2026/05/findnews-en-1726494130.png https://stg-admare-staging.kinsta.cloud/news-events/news-insights/zymeworks-announces-china-nmpa-acceptance-of-biologics-license-application-for-zanidatamab-for-second-line-treatment-of-biliary-tract-cancer/ 2026-06-26T17:47:00+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2026/05/zymeworks-en-1729863234.png https://stg-admare-staging.kinsta.cloud/news-events/news-insights/bright-angel-therapeutics-announces-new-funding-to-advance-therapies-for-invasive-fungal-infections/ 2026-06-26T17:48:06+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2026/06/bright-angel-1652898174.jpg https://stg-admare-staging.kinsta.cloud/news-events/news-insights/immugenia-obtains-pre-seed-funding-from-admare-bioinnovations-acet-capital-and-sherbrooke-innopole-to-develop-a-cancer-treatment-which-would-prevent-relapses/ 2026-06-26T17:48:50+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2026/05/immugenia-en-oct-6-2022-1682724311.png https://stg-admare-staging.kinsta.cloud/news-events/news-insights/admare-portfolio-company-bellus-health-announces-positive-interim-analysis-from-the-phase-2b-soothe-trial-of-blu-5937-in-refractory-chronic-cough/ 2026-06-26T17:49:13+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2026/05/bellus-news-eng-1686146907.png https://stg-admare-staging.kinsta.cloud/news-events/news-insights/zymeworks-announces-fda-clearance-of-investigational-new-drug-application-for-zw191-a-novel-folate-receptor-%e2%8d%ba-targeted-topoisomerase-i-inhibitor-antibody-drug-conjugate/ 2026-06-26T17:50:18+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2026/05/zymeworks-en-1729863234.png https://stg-admare-staging.kinsta.cloud/news-events/news-insights/admare-bioinnovations-opens-applications-for-the-fall-cohorts-of-the-bioinnovation-scientist-programs/ 2026-06-26T17:50:37+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2026/05/bisaug2024en-2-1722964921.png https://stg-admare-staging.kinsta.cloud/news-events/news-insights/sofiac-canada-enables-decarbonization-of-admare-bioinnovations-buildings-with-a-3-275m-investment/ 2026-06-26T17:51:04+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2026/05/admare-infographic-final-eng-1725042806-scaled.jpg https://stg-admare-staging.kinsta.cloud/news-events/news-insights/pharmaessentia-announces-licensing-agreement-with-forus-therapeutics-to-commercialize-besremi-ropeginterferon-alfa-2b-njft-in-canada/ 2026-06-26T17:51:27+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2026/05/forusnews-en-1726061613.png https://stg-admare-staging.kinsta.cloud/news-events/news-insights/abdera-therapeutics-announces-fda-fast-track-designation-for-abd-147-a-next-generation-precision-radiopharmaceutical-therapy-for-the-treatment-of-patients-with-extensive-stage-small-cell-lung-cancer/ 2026-06-26T17:52:00+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2026/05/abdera-therapeutics-en-1726062367.png https://stg-admare-staging.kinsta.cloud/news-events/news-insights/novo-nordisk-to-acquire-inversago-pharma-to-develop-new-therapies-for-people-living-with-obesity-diabetes-and-other-serious-metabolic-diseases/ 2026-06-26T17:52:26+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2026/05/inversago-en-1684857860.png https://stg-admare-staging.kinsta.cloud/news-events/news-insights/castl-announces-site-manager-for-bc-biomanufacturing-training-facility/ 2026-06-26T17:53:37+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2026/05/castl-en-jan-12-2023-1682724080.png https://stg-admare-staging.kinsta.cloud/news-events/news-insights/admare-bioinnovations-welcomes-five-new-start-ups-in-the-national-tx-accelerator/ 2026-06-26T17:53:55+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2026/05/accelmay2024en-1715967046.png https://stg-admare-staging.kinsta.cloud/news-events/news-insights/thryv-therapeutics-granted-fda-orphan-drug-designation-for-lqt-1213-in-long-qt-syndrome-treatment/ 2026-06-26T17:54:22+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2026/05/thryv-therapeutics-eng-1-1758136916-1.png https://stg-admare-staging.kinsta.cloud/news-events/news-insights/zymeworks-announces-first-patient-dosed-in-phase-1-clinical-trial-evaluating-zw171-in-advanced-mesothelin-expressing-cancers/ 2026-06-26T17:55:06+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2026/05/zymeworks-en-1729863234.png https://stg-admare-staging.kinsta.cloud/news-events/news-insights/inversago-pharma-announces-new-data-to-be-presented-at-the-2023-american-thoracic-society-international-conference/ 2026-06-26T17:55:34+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2026/05/inversago-en-1684857860.png https://stg-admare-staging.kinsta.cloud/news-events/news-insights/thryv-therapeutics-announces-positive-phase-1-results-of-thrv-1268-in-obese-participants/ 2026-06-26T18:30:24+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2026/05/thryv-therapeutics-eng-1-1758136916-1.png https://stg-admare-staging.kinsta.cloud/news-events/news-insights/find-therapeutics-announces-series-a-extension-financing-and-appointment-of-dr-thierry-abribat-as-executive-chairman-of-the-board/ 2026-06-26T18:30:56+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2026/05/findnews-en-1726494130.png https://stg-admare-staging.kinsta.cloud/news-events/news-insights/abbvie-and-admare-bioinnovations-foster-life-sciences-innovation-with-the-launch-of-the-abbvie-biotech-innovators-award-in-quebec/ 2026-06-26T18:31:17+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2026/05/announcement-1763994522.png https://stg-admare-staging.kinsta.cloud/news-events/news-insights/amy-rudolph-phd-joins-thryv-therapeutics-board-of-directors-to-support-portfolio-progression-into-heart-failure/ 2026-06-26T18:32:46+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2026/05/thryv-therapeutics-eng-1-1758136916-1.png https://stg-admare-staging.kinsta.cloud/news-events/news-insights/pathway-to-cures-invests-in-seragene-therapeutics/ 2026-06-26T18:33:28+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2026/05/accelmay2024en-1763649271.png https://stg-admare-staging.kinsta.cloud/news-events/news-insights/admare-bioinnovations-expands-with-new-wet-laboratory-space-in-vancouver/ 2026-06-26T18:33:41+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2026/05/june-28th-english-2-1719505568.png https://stg-admare-staging.kinsta.cloud/news-events/news-insights/thryv-therapeutics-receives-fda-ind-clearance-of-thrv-1268-for-heart-failure-and-atrial-fibrillation-and-presents-sgk1-inhibition-results-combined-with-jardiance-in-pressure-overload-model-at-esc-2025/ 2026-06-26T18:33:59+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2026/05/thryv-therapeutics-eng-1-1758136916-1.png https://stg-admare-staging.kinsta.cloud/news-events/news-insights/with-the-u-s-on-uncertain-footing-quebec-must-stand-strong-in-life-sciences/ 2026-06-26T18:34:32+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2026/05/d2d689d995f73d6583f6ef266bf80233-1762383953.webp https://stg-admare-staging.kinsta.cloud/news-events/news-insights/domain-therapeutics-doses-first-patients-in-phase-i-ii-trial-of-dt-7012-targeting-ccr8-in-solid-tumors/ 2026-06-26T18:35:04+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2026/05/domain-tx-en-1686256044.png https://stg-admare-staging.kinsta.cloud/news-events/news-insights/epitopea-strengthens-scientific-advisory-board-with-appointment-of-four-world-renowned-experts-in-cancer-immunology-and-immunotherapy/ 2026-06-26T18:35:58+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2026/05/epitopeanews-en-1739975092.png https://stg-admare-staging.kinsta.cloud/news-events/news-insights/abdera-therapeutics-presents-initial-phase-1-clinical-data-on-abd-147-a-next-generation-dll3-targeting-radiopharmaceutical-therapy-at-iaslc-2025-world-conference-on-lung-cancer/ 2026-06-26T18:36:22+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2026/05/abdera-therapeutics-en-1757440675.png https://stg-admare-staging.kinsta.cloud/news-events/news-insights/specific-biologics-welcomes-paul-j-hastings-as-chair-of-the-board-of-directors/ 2026-06-26T18:37:15+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2026/05/specificen-1749651081.png https://stg-admare-staging.kinsta.cloud/news-events/news-insights/9bio-therapeutics-selected-by-merck-global-health-innovation-fund-and-cqdm-for-strategic-investment-and-acceleration-program/ 2026-06-26T18:37:40+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2025/06/accelmay2024en-2-1740158243.png https://stg-admare-staging.kinsta.cloud/news-events/news-insights/new-admare-institute-report-examines-capital-flows-in-canadian-life-sciences-and-the-urgent-need-to-capture-domestic-economic-value/ 2026-06-26T18:37:59+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2026/05/es-admare-websitetitlecard_01-1752065352.png https://stg-admare-staging.kinsta.cloud/news-events/news-insights/epitopea-expands-its-clinical-development-and-research-capabilities-as-it-accelerates-to-the-clinic/ 2026-06-26T18:38:25+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2026/05/epitopeanews-en-1739975092.png https://stg-admare-staging.kinsta.cloud/news-events/news-insights/admare-executive-institute-opens-applications-for-eighth-cohort/ 2026-06-26T18:38:44+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2026/05/exec-institute-cohort-viii-announcement-1753713280.png https://stg-admare-staging.kinsta.cloud/news-events/news-insights/epitopea-announces-license-and-research-collaboration-agreement-with-msd-to-identify-cryptigentm-tumor-specific-antigens/ 2026-06-26T18:39:12+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2026/05/findnews-en-1726494130.png https://stg-admare-staging.kinsta.cloud/news-events/news-insights/9bio-therapeutics-secures-strategic-funding-to-advance-its-oncology-pipeline/ 2026-06-26T18:39:31+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2025/06/accelmay2024en-2-1740158243.png https://stg-admare-staging.kinsta.cloud/news-events/news-insights/two-key-experts-joining-find-therapeutics-to-accelerate-the-development-of-ftx-101/ 2026-06-26T18:39:54+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2026/05/findnews-en-1726494130.png https://stg-admare-staging.kinsta.cloud/news-events/news-insights/zucara-therapeutics-announces-second-and-final-closing-of-us25-million-series-b-financing/ 2026-06-26T18:40:39+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2026/05/zucaranews-en-1746106365.png https://stg-admare-staging.kinsta.cloud/news-events/news-insights/abdera-therapeutics-announces-fda-clearance-of-ind-application-for-abd-147/ 2026-06-26T18:40:44+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2026/05/abdera-therapeutics-en-1726062367.png https://stg-admare-staging.kinsta.cloud/news-events/news-insights/1-8m-quebec-backed-collaboration-between-9bio-and-vega-advances-precision-oncology-innovation/ 2026-06-26T18:41:01+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2025/06/accelmay2024en-2-1740158243.png https://stg-admare-staging.kinsta.cloud/news-events/news-insights/epitopea-closes-usd-31-million-pre-series-a-financing/ 2026-06-26T18:41:06+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2026/05/epitopeanews-en-1739975092.png https://stg-admare-staging.kinsta.cloud/news-events/news-insights/epitopea-announces-nature-cancer-paper-on-novel-immunotherapy-targets-in-melanoma-and-nsclc/ 2026-06-26T18:41:28+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2026/05/epitopeanews-en-1739975092.png https://stg-admare-staging.kinsta.cloud/news-events/news-insights/zucara-therapeutics-announces-strategic-investment-from-sanofi-as-part-of-us20-million-series-b-financing/ 2026-06-26T18:41:38+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2026/05/zucaranews-en-1746106365.png https://stg-admare-staging.kinsta.cloud/news-events/news-insights/gsk-reaches-agreement-to-acquire-late-stage-biopharmaceutical-company-bellus-health/ 2026-06-26T18:42:18+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2026/05/gskbellus-en-april-18-2023-1682723752.png https://stg-admare-staging.kinsta.cloud/news-events/news-insights/abbvie-and-admare-bioinnovations-announce-rime-therapeutics-as-abbvie-biotech-innovators-award-recipient-in-quebec/ 2026-06-26T18:42:24+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2026/05/announcement-1777575879.png https://stg-admare-staging.kinsta.cloud/news-events/news-insights/cancer-research-uk-and-kisoji-biotechnology-collaborate-to-advance-the-first-naked-antibody-against-trop2-into-the-clinic/ 2026-06-26T18:42:44+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2026/05/kisojinews-en-1733150601.png https://stg-admare-staging.kinsta.cloud/news-events/news-insights/thryv-therapeutics-announces-fda-ind-clearance-of-thrv-1268-for-long-qt-syndrome/ 2026-06-26T18:42:49+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2026/05/thryv-therapeutics-eng-1-1758136916-1.png https://stg-admare-staging.kinsta.cloud/news-events/news-insights/admare-bioinnovations-appoints-marc-riviere-to-its-board-of-directors/ 2026-06-26T18:43:05+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2026/05/marc-riviere-en-1726840265.png https://stg-admare-staging.kinsta.cloud/news-events/news-insights/sutter-health-deploys-worlds-first-wearable-doppler-ultrasound-patch-to-enhance-safety-of-icu-patients/ 2026-06-26T18:43:25+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2026/05/fmen-1722441507.png https://stg-admare-staging.kinsta.cloud/news-events/news-insights/abdera-therapeutics-announces-fda-orphan-drug-designation-for-abd-147-for-the-treatment-of-neuroendocrine-carcinoma/ 2026-06-26T18:43:45+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2026/05/abdera-therapeutics-en-1726062367.png https://stg-admare-staging.kinsta.cloud/news-events/news-insights/find-therapeutics-announces-the-closing-of-a-convertible-note-financing-with-investissement-quebec/ 2026-06-26T18:44:02+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2026/05/findnews-en-1726494130.png https://stg-admare-staging.kinsta.cloud/news-events/news-insights/nanovation-therapeutics-announces-multi-target-partnership-with-novo-nordisk-to-develop-genetic-medicines-targeting-cardiometabolic-and-rare-diseases/ 2026-06-26T18:44:18+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2026/05/zucaranews-en-1726667805.png https://stg-admare-staging.kinsta.cloud/news-events/news-insights/government-of-canada-invests-6-million-to-drive-growth-in-b-c-s-life-sciences-sector/ 2026-06-26T18:44:19+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2026/05/announcement-1738953626.png https://stg-admare-staging.kinsta.cloud/news-events/news-insights/find-therapeutics-announces-first-subject-dosed-in-phase-1-clinical-study-of-ftx-101/ 2026-06-26T18:44:43+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2026/05/findnews-en-1726494130.png https://stg-admare-staging.kinsta.cloud/news-events/news-insights/admare-bioinnovations-2024-highlights/ 2026-06-26T18:44:48+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2026/05/1_cie_eng-1734623744.png https://stg-admare-staging.kinsta.cloud/news-events/news-insights/admare-bioinnovations-celebrates-successes-of-admare-tx-accelerator-companies-concludes-ontario-partnership-with-mars/ 2026-06-26T18:45:01+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2026/05/accelannouncement-coming-soon-1729601312.png https://stg-admare-staging.kinsta.cloud/news-events/news-insights/domain-therapeutics-strengthens-its-intellectual-property-for-its-series-of-treg-depleting-anti-ccr8-antibodies-including-best-in-class-candidate-dt-7012/ 2026-06-26T18:45:17+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2026/05/domain-tx-en-1686256044.png https://stg-admare-staging.kinsta.cloud/news-events/news-insights/thryv-therapeutics-receives-positive-top-line-results-from-wave-i-part-2-clinical-study-in-long-qt-syndrome-type-2-and-type-3-patients/ 2026-06-26T18:45:22+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2026/05/thryv-therapeutics-eng-1-1758136916-1.png https://stg-admare-staging.kinsta.cloud/news-events/news-insights/admare-bioinnovations-welcomes-cohort-vii-of-the-executive-institute-strengthening-canadas-life-sciences-leadership/ 2026-06-26T18:45:29+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2026/05/announcement-3-1733349540.png https://stg-admare-staging.kinsta.cloud/news-events/news-insights/thryv-therapeutics-announces-completion-of-phase-1-dosing-of-its-second-novel-sgk1-inhibitor-thrv-1268-future-studies-in-heart-failure-and-atrial-fibrillation-to-commence-in-2025/ 2026-06-26T18:45:55+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2026/05/thryv-therapeutics-eng-1-1758136916-1.png https://stg-admare-staging.kinsta.cloud/news-events/news-insights/fda-grants-u-s-approval-of-ziihera-zanidatamab-hrii-for-the-treatment-of-adults-with-previously-treated-unresectable-or-metastatic-her2-positive-ihc-3-biliary-tract-cancer-btc/ 2026-06-26T18:47:25+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2026/05/zymeworks-en-1729863234.png https://stg-admare-staging.kinsta.cloud/news-events/news-insights/kisoji-biotechnology-raises-41-million-to-advance-lead-program-into-the-clinic-and-deploy-ai-tools-into-key-pipeline-indications/ 2026-06-26T18:51:50+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2026/05/kisojinews-en-1733150601.png https://stg-admare-staging.kinsta.cloud/news-events/news-insights/admare-bioinnovations-spins-out-analytical-services-to-paraza-pharma-catalyzing-growth-and-innovation/ 2026-06-26T18:52:15+00:00 https://stg-admare-staging.kinsta.cloud/wp-content/uploads/2026/05/paraza-eng-1732803730.png